Clinical Trial Update: Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and tolerability of treprostinil in children with pulmonary arterial hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: AOP Orphan Pharmaceuticals AG | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: RECRUITING